1Cardiology Department, Hospital Universitario de San Juan, Alicante, Spain

2Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain

3Cardiology Department, Hospital Clínico Universitario, Valencia, Spain

4Cardiology Department, Hospital General Universitario de Valencia, Valencia, Spain

5Cardiology Department, Complejo Hospital Universitario de Santiago, Santiago de Compostela, Spain

6Cardiology Department, Hospital de Denia, Denia, Spain

7Cardiology Department, Hospital Universitario de Jaen, Jaen, Spain

8Cardiology Department, Hospital Germans Trias y Pujol, Badalona, Spain

A. Cordero reports a) honoraria for lectures from AstraZeneca, Bristol-Myers Squibb, Ferrer, Boehringer Ingelheim, MSD, and Bristol-Myers Squibb and AMGEN; b) consulting fees from AstraZeneca, Ferrer and AMGEN.

J. Nuñez reports a) honoraria for lectures from AstraZeneca, Boehringer Ingelheim, Eli Lilly Co, Novartis, and Rovi; b) consulting fees from AstraZeneca, Boehringer Ingelheim, Bayer, and Novartis.

L. Fácila reports a) honoraria for lectures from Eli Lilly Co, Daiichi Sankyo, Inc., Bayer, Pfizer, Novartis Boehringer Ingelheim; b) consulting fees from AstraZeneca, Boehringer, Bayer.

M. A. Quintanilla reports a) honoraria for lectures from Astra Zeneca, Boehringer Ingelheim, Eli Lilly, and Rovi; b) consulting fees from Boehringer Ingelheim, Eli Lilly and AstraZeneca

V. Bertomeu-González reports a) honoraria for lectures from Daiichi Sankyo, Boehringer Ingelheim, Bayer, Pfizer-BMS, LivaNova, Ferrer, Cardiome, MSD; b) consulting fees none; c) research grants from Medtronic Iberica.

M. Rodríguez-Mañero report research grants from Fundación Mutua Madrileña, Biosense Webseter, Medtronic and from the Carlos III Institute of Health, Ministry of Economy and Competitiveness (Spain).

J. Torres-Llergo reports a) lecture honoraria from AstraZeneca, Bayer, Boehringer-Ingelheim, Pfizer-BMS, Rovi, Eli Lilly, Novartis and Vifor; b) consulting fees from AstraZeneca, Boehringer, Novartis.

A. Bayes-Genís reports lecture honoraria from Abbott, AstraZeneca, Boehringer-Ingelheim, Novartis, Vifor, Roche Diagnostics, and Critical Diagnostics.

J. R. González-Juanatey reports a) honoraria for lectures from Eli Lilly Co, Daiichi Sankyo, Inc., Bayer, Pfizer, Abbott, Boehringer Ingelheim, MSD, Ferrer, and Bristol-Myers Squibb; b) consulting fees from AstraZeneca, Ferrer, Bayer, Boehringer-Ingelheim; c) research grants from AstraZeneca, Boehringer-Ingelheim and Daichii-Saunkyo.